HPV-RELATED CARCINOMA
Clinical trials for HPV-RELATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for HPV+ head and neck cancer: experimental drug CUE-101 tested
Disease control CompletedThis early-phase study tested a new drug called CUE-101, alone or with pembrolizumab, in 80 adults with HPV16-positive head and neck cancer that had spread or returned. The main goals were to check safety and find the right dose. Researchers also looked at whether the drug helped…
Matched conditions: HPV-RELATED CARCINOMA
Phase: PHASE1 • Sponsor: Cue Biopharma • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
HPV Vaccine's Long-Term power tested in rwandan women
Knowledge-focused CompletedThis completed study looked at how well the HPV vaccine protects against HPV infections over time in over 3,000 Rwandan women aged 18-28, some living with HIV and some without. Researchers collected blood, oral, and other samples to measure vaccine effectiveness and long-term ant…
Matched conditions: HPV-RELATED CARCINOMA
Sponsor: Montefiore Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC